www.fdanews.com/articles/152850-uk-cost-agency-rejects-drugs-from-astrazeneca-bristol-and-roche

UK Cost Agency Rejects Drugs From AstraZeneca, Bristol and Roche

February 1, 2013

Britain’s healthcare cost watchdog NICE said on Friday it was not able to recommend a new diabetes drug from Bristol-Myers Squibb and AstraZeneca, and has asked for more information from the companies.
Reuters